Immune Seven peptides
免疫7肽
Report date: 2025/02/21 16:57:14
NME
Base Information
Drug NameImmune Seven peptides
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (IND)
Highest Status in ChinaPending
Originator CompaniesBeijing Ruiyunhai Biotechnology Co Ltd
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesN/A
Inactive CompaniesNo 302 Hospital Of The People Liberation Army Of ChinaBeijing Ruiyunhai Biotechnology Co Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A